IRS-1(Phospho-Ser612) Rabbit Polyclonal Antibody

This gene encodes a protein which is phosphorylated by insulin receptor tyrosine kinase. Mutations in this gene are associated with type II diabetes and susceptibility to insulin resistance.

The IRS-1(Phospho-Ser612) Rabbit Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of IRS-1 protein phosphorylated at serine 612 residue. This antibody has been meticulously developed using advanced immunization techniques and rigorously validated to ensure optimal performance and reliability.

IRS-1, also known as insulin receptor substrate 1, plays a crucial role in insulin signaling pathways and is involved in various cellular processes, including glucose metabolism, cell growth, and differentiation. Phosphorylation of IRS-1 at serine 612 residue has been implicated in insulin resistance and the development of metabolic disorders such as type 2 diabetes.

The IRS-1(Phospho-Ser612) Rabbit Polyclonal Antibody exhibits exceptional specificity towards the phosphorylated form of IRS-1 at serine 612, enabling precise detection and quantification of this critical post-translational modification. This antibody has been extensively validated using various experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence, ensuring its suitability for a wide range of applications.

With its high sensitivity and low background, the IRS-1(Phospho-Ser612) Rabbit Polyclonal Antibody offers researchers a reliable tool for investigating the role of IRS-1 phosphorylation in insulin signaling and metabolic disorders. Its exceptional performance and robustness make it an indispensable asset for studies aiming to elucidate the molecular mechanisms underlying insulin resistance and related pathologies.

Order the IRS-1(Phospho-Ser612) Rabbit Polyclonal Antibody today and unlock new insights into the intricate world of insulin signaling and metabolic regulation. Trust in its exceptional quality and performance to advance your research and contribute to the understanding and treatment of metabolic disorders.